Baker Bros. Advisors’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-508,323
| Closed | -$4.4M | – | 98 |
|
|
2024
Q2 | $4.4M | Hold |
508,323
| – | – | 0.06% | 69 |
|
|
2024
Q1 | $4.45M | Hold |
508,323
| – | – | 0.06% | 64 |
|
|
2023
Q4 | $3.79M | Hold |
508,323
| – | – | 0.04% | 65 |
|
|
2023
Q3 | $2.93M | Buy |
508,323
+1
| +0% | +$6 | 0.02% | 76 |
|
|
2023
Q2 | $3.66M | Hold |
508,322
| – | – | 0.02% | 81 |
|
|
2023
Q1 | $3.74M | Hold |
508,322
| – | – | 0.02% | 76 |
|
|
2022
Q4 | $3.4M | Hold |
508,322
| – | – | 0.02% | 85 |
|
|
2022
Q3 | $5.2M | Hold |
508,322
| – | – | 0.03% | 77 |
|
|
2022
Q2 | $6.19M | Hold |
508,322
| – | – | 0.04% | 75 |
|
|
2022
Q1 | $10.8M | Hold |
508,322
| – | – | 0.06% | 65 |
|
|
2021
Q4 | $30.6M | Buy |
508,322
+3,333
| +0.7% | +$200K | 0.15% | 47 |
|
|
2021
Q3 | $47.3M | Hold |
504,989
| – | – | 0.21% | 40 |
|
|
2021
Q2 | $83.6M | Hold |
504,989
| – | – | 0.37% | 25 |
|
|
2021
Q1 | $97.3M | Buy |
+504,989
| New | +$97.3M | 0.42% | 22 |
|